Metropolitan Life Insurance CO Jazz Pharmaceuticals PLC Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jun 21, 2023	BUY	$119.87 - $145.67 $1.31 Million - $1.6 Million	10,968 New	10,968 $1.4 Billion
Q3 2021 Jun 21, 2023	BUY	$128.64 - $184.79 $1.43 Million - $2.06 Million	11,127 New	11,127 $1.45 Billion
Q2 2021 Jun 21, 2023	BUY	$160.2 - $186.42 $1.82 Million - $2.11 Million	11,339 New	11,339 $2.01 Billion
Q1 2021 Jun 26, 2023	BUY	$150.19 - $173.5 $1.6 Million - $1.84 Million	10,625 New	10,625 $1.75 Billion
Q4 2020 Jun 22, 2023	BUY	$140.71 - $165.05 $1.4 Million - $1.64 Million	9,959 New	9,959 $1.64 Billion
Q3 2020 Jun 26, 2023	BUY	$105.46 - $144.13 $1.07 Million - $1.47 Million	10,184 New	10,184 $1.45 Billion
Q2 2020 Jun 26, 2023	BUY	$95.68 - $121.88 $105,343 - $134,189	1,101 New	1,101 $121 Million
Q1 2020 Jul 12, 2023	BUY	$87.74 - $152.74 $315,600 - $549,405	3,597 New	3,597 $359 Million
Q4 2019 Jul 12, 2023	BUY	$117.65 - $153.73 $435,893 - $569,569	3,705 New	3,705 $553 Million
Q3 2019 Jul 12, 2023	BUY	$125.18 - $143.24 $472,178 - $540,301	3,772 New	3,772 $483 Million
Q2 2019 Jul 12, 2023	BUY	$125.55 - $144.48 $514,252 - $591,790	4,096 New	4,096 $584 Million
Q1 2019 Jul 13, 2023	BUY	$121.81 - $142.95 $510,262 - $598,817	4,189 New	4,189 $599 Million
Q4 2018 Jul 13, 2023	BUY	$115.94 - $166.74 $495,759 - $712,980	4,276 New	4,276 $530 Million
Q3 2018 Jul 13, 2023	BUY	$161.01 - $180.57 $690,410 - $774,284	4,288 New	4,288 $721 Million
Q3 2018 Nov 14, 2018	SELL	$161.01 - $180.57 $705,706 - $791,438	-4,383 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$146.33 - $183.18 $641,364 - $802,877	4,383 New	4,383 $0

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account